Double-Walled Poly-(D,L-lactide-co-glycolide) (PLGA) and Poly(L-lactide) (PLLA) Nanoparticles for the Sustained Release of Doxorubicin

Double-Walled Poly-(D,L-lactide-co-glycolide) (PLGA) and Poly(L-lactide) (PLLA) Nanoparticles for the Sustained Release of Doxorubicin

Double-walled nanoparticles (DWNPs), containing doxorubicin as a model drug, were produced using poly-(D,L-lactide-co-glycolide) (PLGA) and poly(L-lactide) (PLLA) by the solvent evaporation technique. Double-walled microparticles containing doxorubicin were also produced to make possible the examina...

Full description

Bibliographic Details
Main Authors: M. Margarida Cardoso, Inês N. Peca, Telma Lopes, Rui Gardner, A. Bicho
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Polymers
Subjects:
drug delivery
PLGA/PLLA
double-walled nanoparticles
controlled release
doxorubicin
Online Access:https://www.mdpi.com/2073-4360/13/19/3230

Internet

https://www.mdpi.com/2073-4360/13/19/3230

Similar Items